7th CELL THERAPY SYMPOSIUM
NOVEMBER 3 & 4, 2023
DEAR COLLEAGUES,
Since our last Cell Therapy Symposium only one year has elapsed. Within this short period of time, tremendous progress has been made in our clinic regarding CAR T cell therapy: more than 200 patients have received this innova- tive treatment at our center. In Europe more than 2.000 pa- tients have been treated for acute leukemia, Non-Hodgkin lymphoma and myeloma with remarkable success. Therefore the therapeutical algorithms for the treatment of these diseases need to be revisited. Moreover, the safe manage- ment of cytokine release syndrome, neurotoxicity and pro- longed cytopenia will be highlighted in this symposium. In addition, novel targets and preclinical research for further development of immunogene therapy will be discussed.
We cordially invite all participating physicians, scientists and doctoral fellows to submit abstracts. All abstracts will be presented as poster during the two days of the conference. Best posters will be presented as short talks during the meeting.
Please submit your abstracts till October 5, 2023.
We are looking forward to welcoming you to our symposium.
With very warm regards from Heidelberg
Registration
Program
FRIDAY, 03.11.2023 SCIENTIFIC SYMPOSIUM — PART 1
| 12:30 | Registration, snacks and beverages |
| 12:50 | Satellite Symposium BMS |
| 13:00 | HD-CAR-I trial - reaching new shores |
| 13:20 | BCMA.CARs for multiple myeloma – which way to go? |
| 13:40 | CAR T cells for treatment of mantle cell lymphoma – the GLA perspective |
| 14:00 | CAR T cells for acute myeloid leu- kemia – current perspectives |
| 14:20 | GD2 CAR T cells in solid cancers |
| 14:40 | Lunch Break |
| 15:10 | Cars or Bikes for lymphoma – which one first? Bikes first Cars first |
| 15:50 | The INTEGRATE project M.-L. Schubert |
| 16:10 | Predictive scores in CAR T therapy – ready for the prime time? (HAEMATOTOX, EASIX) F. Korell, Harvard Medical School, USA |
| 16:30 | Armoring CAR T cells against NK cell attack M. Friedrich, Massachusetts Institute of Technology (MIT), USA |
| 16:50 | Break |
| 17:15 - 18:45 | Satellite Symposium BMS |
SATURDAY, 04.11.2023 SCIENTIFIC SYMPOSIUM — PART 2
| 08:00 | Registration, snacks and beverages |
| 08:20 | Multi-target CAR Ts against acute myeloid leukemia (AML) |
| 08:40 | Gene Editing of hematopoietic stem cells (HSCs) |
| 09:00 | CAR T cells manufacturing in an insulator |
| 09:20 | Robotization in T cell manufacturing |
| 09:40 | New CARs for myeloma and lymphoma U. Höpken/A. Rehm, MDC, Berlin |
| 10:00 | Coffee Break |
| 10:20 | Different Subjects |
| 11:00 | CAR-T cells for brain tumors |
| 11:20 | CAR Ts in cardiology |
| 11:40 | CAR T cells in rheumatology |
| 12:00 | CAR T cells for curing SLE |
| 12:20 | Genetic engineering of hematopoietic stem cells P. Derigs, DKFZ Heidelberg |
| 12:40 | Lunch Break |
| 13:15 - 14:45 | Satellite Symposium Kite/Gilead |
Speakers
EXTERNAL SPEAKERS
Dr rer. nat. Kathrin Böpple, RBK Stuttgart
Prof. Dr. Toni Cathomen, Uni Freiburg
Dr. med. Patrick Derigs, DKFZ Heidelberg
Dr. med. Mirco Friedrich, Massachusetts Institut of Technology (MIT)
PD Dr. med. Georg Heß, Uniklinik Mainz
PD Dr. rer. nat. Uta Höpken, MDC, Berlin
Prof. Dr. med. Dr. rer. nat. Ulrike Köhl, Uniklinik Leipzig
Dr. med. Felix Korell, Harvard Medical School, USA
Prof. Dr. med. Claudia Rössig, Uniklinik Münster
Prof. Dr. med. Georg Schett, Uni Erlangen
Dr. med. Christian Seitz, Childrens ́ Hospital Tübingen
Prof. Dr. med. Marion Subklewe, LMU München
INTERNAL SPEAKERS
Prof. Dr. med. Peter Dreger
Dr. rer. nat. Angela Hückelhoven-Krauss
PD Dr. med. Tobias Kessler
Prof. Dr. med. Florian Leuschner
PD Dr. med. Wolfgang Merkt
Prof. Dr. med. Carsten Müller-Tidow
Prof. Dr. med. Marc Raab
Dr. med. Sandra Sauer
Dr. med. Tim Sauer
Dr. med. Ulrike Schäkel
Dr. med. Maria-Luisa Schubert
Prof. Dr. med. Michael Schmitt
Contact
Universitätsklinikum Heidelberg
Medizinische Klinik V, Zelluläre Immuntherapie
Im Neuenheimer Feld 410
69120 Heidelberg
Contact person:
Anna Wolf
06221 56-7989
anna.wolf(at)med.uni-heidelberg.de